Geron Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GERON
GERON has one approved drug.
There are six US patents protecting GERON drugs.
There are one hundred and fifty-five patent family members on GERON drugs in thirty-eight countries and seven supplementary protection certificates in seven countries.
Drugs and US Patents for Geron
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-002 | Jun 6, 2024 | RX | Yes | Yes | 12,442,000 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 12,442,000 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 9,375,485 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-002 | Jun 6, 2024 | RX | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | |||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-002 | Jun 6, 2024 | RX | Yes | Yes | 12,171,778 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 7,494,982 | ⤷ Get Started Free | Y | Y | ⤷ Get Started Free | ||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-002 | Jun 6, 2024 | RX | Yes | Yes | 7,494,982 | ⤷ Get Started Free | Y | Y | ⤷ Get Started Free | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Geron Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 10202103341S | ⤷ Get Started Free |
| Ukraine | 126015 | ⤷ Get Started Free |
| South Korea | 20200033269 | ⤷ Get Started Free |
| Mexico | 2015007169 | ⤷ Get Started Free |
| Australia | 2018282364 | ⤷ Get Started Free |
| New Zealand | 748134 | ⤷ Get Started Free |
| Japan | 2025013669 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Geron Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3456333 | C20250019 | Finland | ⤷ Get Started Free | |
| 3456333 | PA2025517 | Lithuania | ⤷ Get Started Free | PRODUCT NAME: IMETELSTATAS ARBA JO FARMACISKAI PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/24/1894 20250307 |
| 3456333 | 2025C/518 | Belgium | ⤷ Get Started Free | PRODUCT NAME: IMETELSTAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; AUTHORISATION NUMBER AND DATE: EU/1/24/1894 20250311 |
| 3456333 | 301326 | Netherlands | ⤷ Get Started Free | PRODUCT NAME: IMETELSTAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/24/1894 20250311 |
| 3456333 | CR 2025 00016 | Denmark | ⤷ Get Started Free | PRODUCT NAME: IMETELSTAT, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/24/1894 20250311 |
| 3456333 | LUC50005 | Luxembourg | ⤷ Get Started Free | PRODUCT NAME: IMETELSTAT, OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; AUTHORISATION NUMBER AND DATE: EU/1/24/1894 20250311 |
| 3456333 | 122025000019 | Germany | ⤷ Get Started Free | PRODUCT NAME: IMETELSTAT, ODER EIN PHARMAZEUTISCH UNBEDENKLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/24/1894 20250307 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

